Search ARQT
Arcutis Biotherapeutics, Inc.
Nasdaq · CIK 1787306
Last close25.16
Daily change-0.13 (-0.51%)
10 Years gain+15.41%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ARQT · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
59.2Momentum
100.0Acceleration
100.0Confidence
71.0Annual Revenue4
Quarterly Revenue12
Annual CFO8
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality15.6 / 25
Capital Efficiency0.6 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.1503 percentage points.
Operating leverageOperating margin improved by 76.3607 percentage points.
ROIC expansionROIC improved by 183.67 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Heavy share dilution · HIGHDiluted share count increased 107723.893%.
Key Metrics
Revenue Growth TTM117.76%OK
Revenue CAGR 3Y367.27%OK
Gross Margin91.13%OK
Operating Margin0.3%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC1.01%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y107,723.89%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $376.07M | $339.38M | -$12.23M | -$5.63M | -$6.31M | 90.24% | -3.25% | -1.68% | -16.91% | 127.23M |
| 2025 FY Dec 31, 2024 | $196.54M | $177.41M | -$128.40M | -$112.16M | -$112.30M | 90.27% | -65.33% | -57.14% | -366.21% | 120.96M |
| 2025 FY Dec 31, 2023 | $59.61M | $54.62M | -$241.10M | -$247.06M | -$247.49M | 91.63% | -404.49% | -415.2% | -2,327.2% | 69.31M |
| 2024 FY Dec 31, 2022 | $3.69M | $2.93M | -$301.63M | -$257.72M | -$258.05M | 79.54% | -8,183.04% | -7,000.76% | n/a | 55.03M |
| 2023 FY Dec 31, 2021 | n/a | $0.00 | -$206.53M | -$174.63M | -$175.62M | n/a | n/a | n/a | n/a | 49.41M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $415.98M | sum latest 4 fiscal quarters Revenue | OK | 0001787306-26-000051, 0001787306-25-000144 |
| Revenue Growth TTM | 117.76% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001787306-26-000051, 0001787306-25-000144 |
| Revenue CAGR 3Y | 367.27% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001787306-26-000018 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001787306-26-000018 |
| Gross Profit CAGR 3Y | 387.35% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001787306-26-000018 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001787306-26-000051, 0001787306-25-000144 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 91.13% | Gross Profit / Revenue | OK | 0001787306-26-000051, 0001787306-25-000144 |
| Operating Margin | 0.3% | Operating Income / Revenue | OK | 0001787306-26-000051, 0001787306-25-000144 |
| ROIC | 1.01% | NOPAT / Average Invested Capital | OK | 0001787306-26-000051, 0001787306-25-000144 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001787306-26-000051 |
| Current Ratio | 2.92x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 2.19x | (Cash + Short-term Investments) / Total Debt | OK | 0001787306-26-000051 |
| Revenue per Diluted Share | $3.06 | Revenue / Diluted Shares | OK | 0001787306-26-000051, 0001787306-25-000144 |